Narjust Duma, MD, on Advanced NSCLC: Reducing Racial Disparities in Outcomes

February 09, 2022 By The ASCO Post Staff

Narjust Duma, MD, of Dana-Farber Cancer Institute, discusses the many factors that lead to poorer outcomes in lower-income and minority patients with advanced non–small cell lung cancer and the urgent need to address these disparities and physician bias. Women of color and other minority patients are less likely to be offered lung cancer screening; participation in clinical trials; referral to palliative and hospice care services; or genome sequencing of their tumors.

Related Content